Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alasdair J Coles

Showing results (1-10 of 77) with videos related to

Pageof 8
Sort By:
Brain : a Journal of Neurology|September 1, 2023
Chasing MOG antibodies down … assays and lumbar puncturesAlasdair J Coles
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|November 28, 2012
Alemtuzumab therapy for multiple sclerosisAlasdair J Coles
Seminars in Neurology|May 28, 2013
Alemtuzumab treatment of multiple sclerosisAlasdair J Coles
Neurology|September 19, 2018
Author response: Alemtuzumab CARE-MS II 5-year follow-up: Efficacy and safety findingsAlasdair J Coles
Lancet (London, England)|March 11, 2014
Product licences for alemtuzumab and multiple sclerosisAlasdair J Coles, Alastair Compston,
Therapeutic Advances in Neurological Disorders|December 24, 2010
Monoclonal antibodies in multiple sclerosis treatment: current and future stepsClaire L Helliwell, Alasdair J Coles
Experimental Neurology|June 16, 2010
New treatment strategies in multiple sclerosisJoanne L Jones, Alasdair J Coles
Journal of Neurology, Neurosurgery, and Psychiatry|April 17, 2007
Notes on the kidney and its diseases for the neurologistMichael S Zandi, Alasdair J Coles
Experimental Neurology|May 6, 2014
Mode of action and clinical studies with alemtuzumabJoanne L Jones, Alasdair J Coles
Neuro-Degenerative Diseases|December 14, 2007
Campath-1H treatment of multiple sclerosisJoanne L Jones, Alasdair J Coles
Pageof 8

Showing results (1-10 of 77) with videos related to

Sort By:
Pageof 8
Brain : a Journal of Neurology|September 1, 2023
Chasing MOG antibodies down … assays and lumbar puncturesAlasdair J Coles
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|November 28, 2012
Alemtuzumab therapy for multiple sclerosisAlasdair J Coles
Seminars in Neurology|May 28, 2013
Alemtuzumab treatment of multiple sclerosisAlasdair J Coles
Neurology|September 19, 2018
Author response: Alemtuzumab CARE-MS II 5-year follow-up: Efficacy and safety findingsAlasdair J Coles
Lancet (London, England)|March 11, 2014
Product licences for alemtuzumab and multiple sclerosisAlasdair J Coles, Alastair Compston,
Therapeutic Advances in Neurological Disorders|December 24, 2010
Monoclonal antibodies in multiple sclerosis treatment: current and future stepsClaire L Helliwell, Alasdair J Coles
Experimental Neurology|June 16, 2010
New treatment strategies in multiple sclerosisJoanne L Jones, Alasdair J Coles
Journal of Neurology, Neurosurgery, and Psychiatry|April 17, 2007
Notes on the kidney and its diseases for the neurologistMichael S Zandi, Alasdair J Coles
Experimental Neurology|May 6, 2014
Mode of action and clinical studies with alemtuzumabJoanne L Jones, Alasdair J Coles
Neuro-Degenerative Diseases|December 14, 2007
Campath-1H treatment of multiple sclerosisJoanne L Jones, Alasdair J Coles
Pageof 8